Life ScienceCompany
Aegerion Pharmaceuticals M&A Summary
Aegerion Pharmaceuticals has acquired 1 company of its own.
Aegerion Pharmaceuticals’ largest acquisition to date was in 2014, when it acquired Myalept for $325M. Aegerion Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
Aegerion Pharmaceuticals Ownership
Who owns Aegerion Pharmaceuticals?
Aegerion Pharmaceuticals is owned by Amryt Pharma. It was acquired on May 21, 2019.
Was Aegerion Pharmaceuticals formerly PE-backed?
Yes. Aegerion Pharmaceuticals was formerly owned by 1 private investor.
Aegerion Pharmaceuticals Business Overview
Where is Aegerion Pharmaceuticals headquartered?
Aegerion Pharmaceuticals is headquartered in Cambridge, Massachusetts.
What is Aegerion Pharmaceuticals’ revenue?
Aegerion Pharmaceuticals disclosed revenue of 240M USD for 2015 and 158M USD for 2014.
How many employees does Aegerion Pharmaceuticals have?
Aegerion Pharmaceuticals has 307 employees.
What sector is Aegerion Pharmaceuticals in?
Aegerion Pharmaceuticals is a life science company.
When was Aegerion Pharmaceuticals founded?
Aegerion Pharmaceuticals was founded in 2005.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
